NeuroSense Therapeutics
NRSN
NRSN
7 hedge funds and large institutions have $1.87M invested in NeuroSense Therapeutics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
Armistice Capital
New York
|
$1.77M |
2 |
XT
XTX Topco
George Town,
Cayman Islands
|
$36.6K |
Top Sellers
1 |
Renaissance Technologies
New York
|
$0 |
2 |
WP
Woodline Partners
San Francisco,
California
|
$0 |
3 |
UBS Group
Zurich,
Switzerland
|
$0 |
4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
$44.8K |